Northwestern Mutual Wealth Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-9
Closed -$194 – 4389
2026
Q1
$194 Buy
9
+8
+800% +$173 ﹤0.01% 3943
2025
Q4
$24 Hold
1
– – ﹤0.01% 3941
2025
Q3
$14 Hold
1
– – ﹤0.01% 3760
2025
Q2
$8 Hold
1
– – ﹤0.01% 3633
2025
Q1
$8 Hold
1
– – ﹤0.01% 3628
2024
Q4
$15 Hold
1
– – ﹤0.01% 3551
2024
Q3
$15 Hold
1
– – ﹤0.01% 3556
2024
Q2
$15 Hold
1
– – ﹤0.01% 3451
2024
Q1
$19 Hold
1
– – ﹤0.01% 3514
2023
Q4
$19 Hold
1
– – ﹤0.01% 3429
2023
Q3
$18 Hold
1
– – ﹤0.01% 3245
2023
Q2
$20 Hold
1
– – ﹤0.01% 3307
2023
Q1
$18 Hold
1
– – ﹤0.01% 3309
2022
Q4
$21 Hold
1
– – ﹤0.01% 3276
2022
Q3
$0 Hold
1
– – ﹤0.01% 3344
2022
Q2
$0 Hold
1
– – ﹤0.01% 3423
2022
Q1
$0 Hold
1
– – ﹤0.01% 3345
2021
Q4
$0 Hold
1
– – ﹤0.01% 3292
2021
Q3
$0 Sell
1
-2,314
-100% -$72K ﹤0.01% 3177
2021
Q2
$64K Buy
+2,315
New +$66.1K ﹤0.01% 1762

Other funds holding RCUS

Northwestern Mutual Wealth Management's RCUS Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 9 shares — an estimated $194 sold.

Northwestern Mutual Wealth Management first reported a position in RCUS in Q2 2021 and held it in 20 quarters. The position peaked at $64K in Q2 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 9 Arcus Biosciences shares in Q2 2026, an estimated $194.
  • Northwestern Mutual Wealth Management first reported a position in Arcus Biosciences in Q2 2021 and held it in 20 quarters.
  • Northwestern Mutual Wealth Management's Arcus Biosciences position peaked at $64K in Q2 2021.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.